Interleukin-10 inhibits interleukin-1β production and inflammasome activation of microglia in epileptic seizures

Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuroinflammation Vol. 16; no. 1; pp. 66 - 13
Main Authors Sun, Yi, Ma, Jiangjun, Li, Dongfang, Li, Pinggan, Zhou, Xiaolin, Li, Yu, He, Zhanwen, Qin, Lijun, Liang, Liyang, Luo, Xiangyang
Format Journal Article
LanguageEnglish
Published London BioMed Central 28.03.2019
BMC
Subjects
Online AccessGet full text
ISSN1742-2094
1742-2094
DOI10.1186/s12974-019-1452-1

Cover

Abstract Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model. Methods In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting. Results Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β. Conclusions Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments.
AbstractList Abstract Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model. Methods In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting. Results Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β. Conclusions Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments.
Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model.BACKGROUNDMicroglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model.In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting.METHODSIn this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting.Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β.RESULTSOur results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β.Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments.CONCLUSIONSOur results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments.
Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model. In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting. Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β. Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments.
Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model. Methods In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting. Results Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β. Conclusions Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments.
Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model. Methods In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting. Results Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β. Conclusions Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments.
ArticleNumber 66
Author Zhou, Xiaolin
Li, Yu
Qin, Lijun
Li, Dongfang
Liang, Liyang
Luo, Xiangyang
Li, Pinggan
He, Zhanwen
Ma, Jiangjun
Sun, Yi
Author_xml – sequence: 1
  givenname: Yi
  surname: Sun
  fullname: Sun, Yi
  organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
– sequence: 2
  givenname: Jiangjun
  surname: Ma
  fullname: Ma, Jiangjun
  organization: Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
– sequence: 3
  givenname: Dongfang
  surname: Li
  fullname: Li, Dongfang
  organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
– sequence: 4
  givenname: Pinggan
  surname: Li
  fullname: Li, Pinggan
  organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
– sequence: 5
  givenname: Xiaolin
  surname: Zhou
  fullname: Zhou, Xiaolin
  organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
– sequence: 6
  givenname: Yu
  surname: Li
  fullname: Li, Yu
  organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
– sequence: 7
  givenname: Zhanwen
  surname: He
  fullname: He, Zhanwen
  organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
– sequence: 8
  givenname: Lijun
  surname: Qin
  fullname: Qin, Lijun
  organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
– sequence: 9
  givenname: Liyang
  surname: Liang
  fullname: Liang, Liyang
  organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
– sequence: 10
  givenname: Xiangyang
  orcidid: 0000-0003-1325-3106
  surname: Luo
  fullname: Luo, Xiangyang
  email: luoxy33@sina.cn
  organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30922332$$D View this record in MEDLINE/PubMed
BookMark eNp9Ustu1DAUtVARfcAHsEGR2LAJ-BHb8QYJVRRGqsQG1pbj3Ew9OPbUTirBZ_EhfFM9k1KmlWBl695zjo_vPafoKMQACL0k-C0hrXiXCVWyqTFRNWk4rckTdEJkQ2uKVXN0cD9GpzlvMGaUC_oMHTOsKGWMnqDrVZggeZi_u1ATXLlw5To35XI5qP_-VW1T7Gc7uRgqE_rSHrwZR5PjCJUp9Ruz78WhGp1Nce2dKaAKts7DdnK2yuB-zgnyc_R0MD7Di7vzDH27-Pj1_HN9-eXT6vzDZW05E1PNlTIwtB1I3Nt2UEQarlrZtT2xAmMhmQBKByOh6yy3jbGct71gbKADVw1nZ2i16PbRbPQ2udGkHzoap_eFmNbapGLMgwYqsLSqp0yVOVrWcSt4o2wvWwuc2KL1ftHazt0IvYUwJeMfiD7sBHel1_FGi4ZJRVQReHMnkOL1DHnSo8sWvDcB4pw1pRjLVrR8B339CLqJcwplVAVFSINbIUhBvTp0dG_lz2YLgCyAsoycEwz3EIL1Lj16SY8u6dG79OidqHzEsW7a77V8yvn_MunCzOWVsIb01_S_SbeTxtsY
CitedBy_id crossref_primary_10_20307_nps_2024_30_1_30
crossref_primary_10_3390_cosmetics7040082
crossref_primary_10_3390_ijms21207448
crossref_primary_10_3390_ijms22052573
crossref_primary_10_1016_j_peptides_2021_170581
crossref_primary_10_2174_1566524023666230731095431
crossref_primary_10_3389_fimmu_2023_1226196
crossref_primary_10_1016_j_jneuroim_2020_577343
crossref_primary_10_7717_peerj_17252
crossref_primary_10_1007_s12264_023_01170_2
crossref_primary_10_3390_biom10101437
crossref_primary_10_1002_glia_24323
crossref_primary_10_1016_j_chembiol_2021_07_014
crossref_primary_10_1016_j_jchemneu_2020_101849
crossref_primary_10_1002_cti2_1299
crossref_primary_10_1007_s00210_021_02175_2
crossref_primary_10_1007_s00109_020_01988_7
crossref_primary_10_34172_PS_2020_32
crossref_primary_10_3389_fbioe_2021_754952
crossref_primary_10_3390_ijms231810266
crossref_primary_10_1007_s11011_024_01391_y
crossref_primary_10_1016_j_yebeh_2022_108615
crossref_primary_10_7554_eLife_88686_3
crossref_primary_10_1007_s10072_021_05331_x
crossref_primary_10_3389_fpsyt_2023_1180929
crossref_primary_10_1016_j_eplepsyres_2022_107018
crossref_primary_10_3390_immuno2040040
crossref_primary_10_1124_jpet_120_000004
crossref_primary_10_1016_j_clim_2022_108935
crossref_primary_10_1007_s11756_021_00911_w
crossref_primary_10_1016_j_jbc_2023_105205
crossref_primary_10_1186_s12974_020_01944_9
crossref_primary_10_1016_j_omtn_2023_102065
crossref_primary_10_1039_D2FO01490D
crossref_primary_10_3390_biomedicines12020410
crossref_primary_10_3390_ijms251910537
crossref_primary_10_1186_s12989_024_00589_3
crossref_primary_10_3390_biomedicines11102825
crossref_primary_10_1007_s12035_024_04359_2
crossref_primary_10_14202_vetworld_2024_1655_1660
crossref_primary_10_1016_j_jneumeth_2021_109194
crossref_primary_10_1111_epi_16424
crossref_primary_10_1155_2021_7946252
crossref_primary_10_3389_fcell_2021_740758
crossref_primary_10_1021_acs_jmedchem_4c01176
crossref_primary_10_7554_eLife_88686
crossref_primary_10_3390_antiox9100970
crossref_primary_10_1016_j_brainresbull_2021_05_001
crossref_primary_10_1007_s12026_022_09286_9
crossref_primary_10_1016_j_bbi_2021_08_223
crossref_primary_10_1016_j_intimp_2025_114329
crossref_primary_10_3390_microorganisms10050911
crossref_primary_10_1016_j_intimp_2024_112386
crossref_primary_10_3136_fstr_FSTR_D_23_00246
crossref_primary_10_1111_iej_13633
crossref_primary_10_1111_epi_18038
crossref_primary_10_3389_fcell_2021_790437
crossref_primary_10_1155_2020_3649613
crossref_primary_10_18632_aging_202491
crossref_primary_10_3389_fphar_2020_00372
crossref_primary_10_1016_j_eplepsyres_2021_106588
crossref_primary_10_1039_D4BM01530D
crossref_primary_10_1038_s41540_024_00473_y
crossref_primary_10_1038_s41598_022_22806_9
crossref_primary_10_3390_cells12212570
crossref_primary_10_1155_2019_8928934
crossref_primary_10_3390_nano11102510
crossref_primary_10_1038_s41467_022_33542_z
crossref_primary_10_1002_brb3_2011
crossref_primary_10_3390_cells10061524
crossref_primary_10_1186_s10194_021_01353_0
crossref_primary_10_1007_s11064_021_03367_1
crossref_primary_10_1172_jci_insight_178216
crossref_primary_10_2147_CMAR_S244374
crossref_primary_10_3390_biomedicines11040999
crossref_primary_10_1002_glia_24255
crossref_primary_10_1155_2021_5567046
crossref_primary_10_1007_s11064_023_03951_7
crossref_primary_10_1021_acsptsci_4c00556
crossref_primary_10_1007_s10571_023_01429_2
crossref_primary_10_1007_s11095_023_03552_7
crossref_primary_10_1186_s12883_020_01825_x
crossref_primary_10_1186_s12974_020_01854_w
crossref_primary_10_2147_JIR_S469451
crossref_primary_10_3390_tropicalmed9010013
crossref_primary_10_1016_j_it_2020_02_002
crossref_primary_10_3389_fvets_2023_1258244
crossref_primary_10_3389_fcell_2024_1406330
crossref_primary_10_3389_fnmol_2024_1430080
crossref_primary_10_1007_s13596_021_00573_8
crossref_primary_10_1007_s11064_021_03267_4
crossref_primary_10_18632_aging_205970
crossref_primary_10_3389_fcell_2021_630645
crossref_primary_10_3390_ijms25116078
Cites_doi 10.1016/0014-2999(91)90152-G
10.1016/j.neurobiolaging.2017.08.022
10.1101/cshperspect.a022699
10.1186/s12974-016-0531-9
10.1016/j.yebeh.2015.04.063
10.1111/j.1528-1167.2005.00298.x
10.4049/jimmunol.180.12.7827
10.1038/nrneurol.2010.178
10.1038/nrn752
10.1111/epi.13100
10.1046/j.1471-4159.1994.63051872.x
10.1016/j.pharep.2014.06.005
10.1002/glia.20554
10.1186/s12974-016-0727-z
10.1016/B978-0-444-52898-8.00010-0
10.1016/j.jneuroim.2015.04.003
10.3892/ijmm.2016.2656
10.1016/S0969-9961(03)00127-X
10.1111/j.1528-1167.2010.02606.x
10.1002/jcla.20374
10.1186/s12906-018-2287-5
10.2147/IJN.S31050
10.1111/epi.12354
10.1523/JNEUROSCI.1901-08.2008
10.1038/ni.1703
10.1016/j.immuni.2010.05.007
10.1016/j.vaccine.2009.03.034
10.1002/epi4.12036
10.1016/j.yebeh.2014.04.009
10.1186/1742-2094-9-126
10.1073/pnas.1008155107
10.1007/s00018-008-8521-4
10.1021/nn404473g
10.1016/j.intimp.2014.12.035
10.1074/jbc.M607594200
10.1016/j.cyto.2015.06.017
10.1016/j.nbd.2006.06.003
10.1016/j.bbi.2008.03.009
10.1523/JNEUROSCI.19-12-05054.1999
10.1038/nrneurol.2010.17
10.1007/s12035-015-9593-4
10.1111/imr.12617
10.1007/s00281-007-0085-0
10.1016/j.nbd.2007.01.015
10.1016/j.pbb.2009.10.003
10.2174/0929867321666141106124657
10.1002/glia.23008
10.1523/JNEUROSCI.1820-08.2008
10.1038/nature10759
10.1016/j.eplepsyres.2009.09.004
10.1523/JNEUROSCI.4058-14.2015
10.1007/s13311-011-0039-z
10.3345/kjp.2013.56.7.271
10.1186/s12974-016-0546-2
10.1016/j.jneuroim.2010.05.016
10.1016/S0006-8993(02)03050-0
10.1007/s11481-009-9164-4
10.1016/j.immuni.2009.02.005
ContentType Journal Article
Copyright The Author(s). 2019
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s). 2019
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12974-019-1452-1
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1742-2094
EndPage 13
ExternalDocumentID oai_doaj_org_article_e2607c9d239145c3b5c6549cd78ce51c
PMC6437919
30922332
10_1186_s12974_019_1452_1
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
AAYXX
ALIPV
CITATION
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c536t-599aef8be70dc8f917a5987b8d1c6006736e22fa7ebbc5c4ac558d633f2f59453
IEDL.DBID M48
ISSN 1742-2094
IngestDate Wed Aug 27 01:23:55 EDT 2025
Thu Aug 21 18:45:36 EDT 2025
Fri Sep 05 04:45:37 EDT 2025
Fri Jul 25 04:43:54 EDT 2025
Wed Feb 19 02:34:01 EST 2025
Tue Jul 01 02:54:30 EDT 2025
Thu Apr 24 23:10:05 EDT 2025
Sat Sep 06 07:29:52 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords IL-1β
Epilepsy
IL-10
Microglia
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-599aef8be70dc8f917a5987b8d1c6006736e22fa7ebbc5c4ac558d633f2f59453
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-1325-3106
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12974-019-1452-1
PMID 30922332
PQID 2211408661
PQPubID 55345
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_e2607c9d239145c3b5c6549cd78ce51c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6437919
proquest_miscellaneous_2200786859
proquest_journals_2211408661
pubmed_primary_30922332
crossref_primary_10_1186_s12974_019_1452_1
crossref_citationtrail_10_1186_s12974_019_1452_1
springer_journals_10_1186_s12974_019_1452_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-03-28
PublicationDateYYYYMMDD 2019-03-28
PublicationDate_xml – month: 03
  year: 2019
  text: 2019-03-28
  day: 28
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Journal of neuroinflammation
PublicationTitleAbbrev J Neuroinflammation
PublicationTitleAlternate J Neuroinflammation
PublicationYear 2019
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References CA Colton (1452_CR16) 2009; 4
FJ Sun (1452_CR19) 2016; 13
M Maldonado (1452_CR5) 2003; 14
B Freche (1452_CR45) 2007; 29
IC Allen (1452_CR37) 2009; 30
AM Minogue (1452_CR34) 2012; 9
A Vezzani (1452_CR8) 2012; 107
A Vezzani (1452_CR46) 2015; 6
MA Galic (1452_CR25) 2008; 28
A Sokka (1452_CR1) 2017; 2
A Vezzani (1452_CR2) 2005; 46
A Crespel (1452_CR4) 2002; 952
E Avignone (1452_CR18) 2008; 28
JW Choi (1452_CR35) 2016; 38
T Strowig (1452_CR42) 2012; 481
A Vezzani (1452_CR9) 1999; 19
Z Xiao (1452_CR13) 2015; 282
S Auvin (1452_CR47) 2010; 51
T Takenouchi (1452_CR28) 2008; 180
VH Perry (1452_CR15) 2010; 6
K Riazi (1452_CR24) 2010; 89
L Franchi (1452_CR43) 2009; 10
SL Demento (1452_CR41) 2009; 27
TD Kanneganti (1452_CR38) 2006; 281
MY Huang (1452_CR27) 2018; 18
S Gordon (1452_CR17) 2010; 32
PF Fabene (1452_CR21) 2010; 224
B Steinborn (1452_CR10) 2014; 66
V Sackmann (1452_CR55) 2017; 60
KI Strauss (1452_CR48) 2016; 13
E Kosonowska (1452_CR23) 2015; 49
M Maroso (1452_CR53) 2011; 8
S Singh (1452_CR29) 2010; 94
TL Gouveia (1452_CR59) 2014; 36
A Moquin (1452_CR26) 2013; 7
SM Kamal (1452_CR31) 2012; 7
ML Diamond (1452_CR14) 2015; 56
JG Sheng (1452_CR3) 1994; 63
X Li (1452_CR22) 1642; 2016
IC Chou (1452_CR50) 2010; 24
CC Chio (1452_CR56) 2015; 22
L Xu (1452_CR40) 2016; 53
S Moorlag (1452_CR51) 2018; 281
O Giorgi (1452_CR30) 1991; 193
J Vinet (1452_CR32) 2016; 64
A Cianciulli (1452_CR36) 2015; 24
T Ravizza (1452_CR7) 2006; 24
E Aronica (1452_CR6) 2007; 26
C Roseti (1452_CR20) 2013; 54
J Palomo (1452_CR52) 2015; 76
Y Youn (1452_CR58) 2013; 56
AS Yazdi (1452_CR44) 2010; 107
A Vezzani (1452_CR49) 2008; 22
Z Zhang (1452_CR11) 2008; 65
AH Haas de (1452_CR33) 2007; 55
A Vezzani (1452_CR39) 2011; 7
AM Bhandare (1452_CR57) 2015; 35
MD Nguyen (1452_CR12) 2002; 3
TA Siddiqui (1452_CR54) 2016; 13
References_xml – volume: 193
  start-page: 363
  year: 1991
  ident: 1452_CR30
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(91)90152-G
– volume: 60
  start-page: 173
  year: 2017
  ident: 1452_CR55
  publication-title: Neurobiol Aging
  doi: 10.1016/j.neurobiolaging.2017.08.022
– volume: 6
  start-page: a022699
  year: 2015
  ident: 1452_CR46
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a022699
– volume: 13
  start-page: 66
  year: 2016
  ident: 1452_CR54
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-016-0531-9
– volume: 49
  start-page: 66
  year: 2015
  ident: 1452_CR23
  publication-title: Epilepsy Behav
  doi: 10.1016/j.yebeh.2015.04.063
– volume: 46
  start-page: 1724
  year: 2005
  ident: 1452_CR2
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2005.00298.x
– volume: 180
  start-page: 7827
  year: 2008
  ident: 1452_CR28
  publication-title: J Immunol
  doi: 10.4049/jimmunol.180.12.7827
– volume: 7
  start-page: 31
  year: 2011
  ident: 1452_CR39
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2010.178
– volume: 3
  start-page: 216
  year: 2002
  ident: 1452_CR12
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn752
– volume: 56
  start-page: 991
  year: 2015
  ident: 1452_CR14
  publication-title: Epilepsia
  doi: 10.1111/epi.13100
– volume: 63
  start-page: 1872
  year: 1994
  ident: 1452_CR3
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1994.63051872.x
– volume: 66
  start-page: 972
  year: 2014
  ident: 1452_CR10
  publication-title: Pharmacol Rep
  doi: 10.1016/j.pharep.2014.06.005
– volume: 55
  start-page: 1374
  year: 2007
  ident: 1452_CR33
  publication-title: Glia
  doi: 10.1002/glia.20554
– volume: 13
  start-page: 270
  year: 2016
  ident: 1452_CR48
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-016-0727-z
– volume: 107
  start-page: 163
  year: 2012
  ident: 1452_CR8
  publication-title: Handb Clin Neurol
  doi: 10.1016/B978-0-444-52898-8.00010-0
– volume: 282
  start-page: 110
  year: 2015
  ident: 1452_CR13
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2015.04.003
– volume: 38
  start-page: 666
  year: 2016
  ident: 1452_CR35
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2016.2656
– volume: 14
  start-page: 279
  year: 2003
  ident: 1452_CR5
  publication-title: Neurobiol Dis
  doi: 10.1016/S0969-9961(03)00127-X
– volume: 51
  start-page: 34
  issue: Suppl 3
  year: 2010
  ident: 1452_CR47
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2010.02606.x
– volume: 24
  start-page: 154
  year: 2010
  ident: 1452_CR50
  publication-title: J Clin Lab Anal
  doi: 10.1002/jcla.20374
– volume: 18
  start-page: 221
  year: 2018
  ident: 1452_CR27
  publication-title: BMC Complement Altern Med
  doi: 10.1186/s12906-018-2287-5
– volume: 7
  start-page: 2583
  year: 2012
  ident: 1452_CR31
  publication-title: Int J Nanomedicine
  doi: 10.2147/IJN.S31050
– volume: 54
  start-page: 1834
  year: 2013
  ident: 1452_CR20
  publication-title: Epilepsia
  doi: 10.1111/epi.12354
– volume: 28
  start-page: 6904
  year: 2008
  ident: 1452_CR25
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1901-08.2008
– volume: 10
  start-page: 241
  year: 2009
  ident: 1452_CR43
  publication-title: Nat Immunol
  doi: 10.1038/ni.1703
– volume: 32
  start-page: 593
  year: 2010
  ident: 1452_CR17
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.05.007
– volume: 27
  start-page: 3013
  year: 2009
  ident: 1452_CR41
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.03.034
– volume: 2
  start-page: 76
  year: 2017
  ident: 1452_CR1
  publication-title: Epilepsia Open
  doi: 10.1002/epi4.12036
– volume: 36
  start-page: 68
  year: 2014
  ident: 1452_CR59
  publication-title: Epilepsy Behav
  doi: 10.1016/j.yebeh.2014.04.009
– volume: 9
  start-page: 126
  year: 2012
  ident: 1452_CR34
  publication-title: J Neuroinflammation
  doi: 10.1186/1742-2094-9-126
– volume: 107
  start-page: 19449
  year: 2010
  ident: 1452_CR44
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1008155107
– volume: 65
  start-page: 4055
  year: 2008
  ident: 1452_CR11
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-008-8521-4
– volume: 7
  start-page: 9585
  year: 2013
  ident: 1452_CR26
  publication-title: ACS Nano
  doi: 10.1021/nn404473g
– volume: 24
  start-page: 369
  year: 2015
  ident: 1452_CR36
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2014.12.035
– volume: 281
  start-page: 36560
  year: 2006
  ident: 1452_CR38
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M607594200
– volume: 76
  start-page: 25
  year: 2015
  ident: 1452_CR52
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2015.06.017
– volume: 24
  start-page: 128
  year: 2006
  ident: 1452_CR7
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2006.06.003
– volume: 22
  start-page: 797
  year: 2008
  ident: 1452_CR49
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2008.03.009
– volume: 19
  start-page: 5054
  year: 1999
  ident: 1452_CR9
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.19-12-05054.1999
– volume: 6
  start-page: 193
  year: 2010
  ident: 1452_CR15
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2010.17
– volume: 53
  start-page: 6709
  year: 2016
  ident: 1452_CR40
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-015-9593-4
– volume: 281
  start-page: 28
  year: 2018
  ident: 1452_CR51
  publication-title: Immunol Rev
  doi: 10.1111/imr.12617
– volume: 29
  start-page: 249
  year: 2007
  ident: 1452_CR45
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-007-0085-0
– volume: 26
  start-page: 497
  year: 2007
  ident: 1452_CR6
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2007.01.015
– volume: 94
  start-page: 416
  year: 2010
  ident: 1452_CR29
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/j.pbb.2009.10.003
– volume: 22
  start-page: 759
  year: 2015
  ident: 1452_CR56
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141106124657
– volume: 64
  start-page: 1350
  year: 2016
  ident: 1452_CR32
  publication-title: Glia
  doi: 10.1002/glia.23008
– volume: 28
  start-page: 9133
  year: 2008
  ident: 1452_CR18
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1820-08.2008
– volume: 481
  start-page: 278
  year: 2012
  ident: 1452_CR42
  publication-title: Nature
  doi: 10.1038/nature10759
– volume: 89
  start-page: 34
  year: 2010
  ident: 1452_CR24
  publication-title: Epilepsy Res
  doi: 10.1016/j.eplepsyres.2009.09.004
– volume: 35
  start-page: 2191
  year: 2015
  ident: 1452_CR57
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4058-14.2015
– volume: 8
  start-page: 304
  year: 2011
  ident: 1452_CR53
  publication-title: Neurotherapeutics
  doi: 10.1007/s13311-011-0039-z
– volume: 56
  start-page: 271
  year: 2013
  ident: 1452_CR58
  publication-title: Korean J Pediatr
  doi: 10.3345/kjp.2013.56.7.271
– volume: 13
  start-page: 85
  year: 2016
  ident: 1452_CR19
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-016-0546-2
– volume: 224
  start-page: 22
  year: 2010
  ident: 1452_CR21
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2010.05.016
– volume: 952
  start-page: 159
  year: 2002
  ident: 1452_CR4
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(02)03050-0
– volume: 4
  start-page: 399
  year: 2009
  ident: 1452_CR16
  publication-title: J NeuroImmune Pharmacol
  doi: 10.1007/s11481-009-9164-4
– volume: 2016
  start-page: 487
  year: 1642
  ident: 1452_CR22
  publication-title: Brain Res
– volume: 30
  start-page: 556
  year: 2009
  ident: 1452_CR37
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.02.005
SSID ssj0032562
Score 2.5449998
Snippet Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β...
Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by...
Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β...
Abstract Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 66
SubjectTerms Animals
Autocrine signalling
Biomedical and Life Sciences
Biomedicine
Brain - pathology
Brain research
Caspase
Caspase-1
Cell adhesion & migration
Cells, Cultured
Central nervous system
Convulsants - toxicity
Convulsions & seizures
Cytokines
Cytokines - genetics
Cytokines - metabolism
Disease
Disease Models, Animal
Encephalopathy
Enzyme-linked immunosorbent assay
Epilepsy
Flow cytometry
Gene Expression Regulation - drug effects
Glial cells
IL-10
IL-1β
Immunology
Inflammasomes
Inflammation
Interleukin 10
Interleukin-10 - pharmacology
Interleukin-1beta - metabolism
Lipopolysaccharides
Lipopolysaccharides - toxicity
Male
Mice
Mice, Inbred C57BL
Microglia
Microglia - drug effects
Microglia - metabolism
Nervous system
Neurobiology
Neurology
Neuronal-glial interactions
Neurosciences
Nucleic Acids - genetics
Nucleic Acids - metabolism
Picrotoxin
Picrotoxin - toxicity
Polyclonal antibodies
Polymerase chain reaction
Reverse transcription
RNA, Small Interfering - pharmacology
Seizures
Seizures - chemically induced
Seizures - metabolism
Seizures - pathology
Signal Transduction - drug effects
Signal Transduction - genetics
Stat3 protein
STAT3 Transcription Factor - metabolism
Tumor necrosis factor-TNF
Western blotting
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4s1CQUbiBLLq9-MIiKpCghOVerP8Co3YzS5k98LP6g_pb2KcZJcuzwu3yJ441sx4PJ9nMkbouQwW0LFiRAhNiSyFkmhZISnCo41CxTBU-_ygT07luzN1duWqr5oTNpYHHhl3VMDhNsllLhyTKomokgZMk7KxqSiWqvWljm7B1GiDBWzkfIphMquPetjVTM22cAQG4YTt7UJDsf7feZi_Jkr-FC0dNqHjW-jm5D3iV-Osb6NrpbuDrr-f4uN30ZfhgG9eNp_bDkwfbrvzNrbrHrdX2y8v8Gos9ApCwaHL0N2AZixCv1wUXH91GA9q8bLBi5qx92neBiDCZQVGBIxMwn1pv20Aqt9Dp8dvP745IdOlCiQpoddEORdKY2MxNCfbAFoLylkTbWZJD9fW6MJ5E0yJMakkQ1LKZi1EwxvlpBL30UG37MpDhGk0JTTS2WyojCxEqVXOAVwSYUKTzQzRLZN9miqO14sv5n5AHlb7US4e5OKrXDyboRe7V1ZjuY2_Eb-uktsR1krZQwPoj5_0x_9Lf2bocCt3Py3f3nOAxRLAnoZvPNt1w8Kr0ZTQleWm0lT3SlvlZujBqCa7mQjqwO0SfIbMngLtTXW_p2vPh-LeNZDqGIz5cqtqP6b1R048-h-ceIxu8LpCqCDcHqKD9ddNeQIe1zo-HRbXd2kKKU4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3JbtQw1IIiIS6IvSkFGYkTyGoc7ycEiKpCghOV5hZ5Sxsxk0ybmQuf1Q_hm3h2MlOGpbfIfo4cv8Vvy3sIveZWg3UsKGFMloTHWBKnaSTewaN2TDibq31-lSen_PNMzCaH2zClVW5kYhbUoffJR35UgaXCQf-W9N3ygqSuUSm6OrXQuI3uUNBEUusGNdsaXAyu82qKZFItjwa421TKuTCEclERunMX5ZL9_9Iz_06X_CNmmq-i4wfo_qRD4vcj0h-iW7F7hO5-maLkj9FFdvPN4_p724EAxG133rp2NeD29_GfV3g5lnsF1GDbBZhugD4WdugXEacfHkZ3Le4bvEh5e2fz1gIQjksQJSBqPB5i-2MNBvsTdHr86dvHEzK1ViBeMLkiwhgbG-2iKoPXDdhsVhitnA7Uy9y8RsaqaqyKznnhufVC6CAZa6pGGC7YU7TX9V3cR7h0KtqGGx1UyR21jksRggXFhCnbBFWgcnPItZ_qjqf2F_M62x9a1iNeasBLnfBS0wK92S5ZjkU3bgL-kDC3BUz1svNAf3lWT-xXRzDblDehYgZWeeaEl2AZ-6C0j4L6Ah1u8F5PTDzU1yRXoFfbaWC_FFOxXezXCSYpWVILU6BnI5lsd8JKA8oXqwqkdghoZ6u7M117nkt8p3CqofDOtxtSu97Wf0_i4OaPeI7uVYn2S0YqfYj2Vpfr-AI0qpV7mdnmF1jlIOg
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQkRAXxJtAQUbiBLJI_PYRVlQVEpyo1JvlV2jEbnZLdi_8rP6Q_ibGTnbpQkHiFsXjxPI8P489RugVdxrQsWgIY7ImPKWaeN0kEjw8as-Ed6Xa52d5fMI_norTqVh0PgtzNX_faPl2AH-k8j4JQxouKAGgc1OA3c3CPJOzrdFl4LnplLS8ttue2ynV-a8LKf_cGflberR4naO76M4ULuJ3I3_voRupv49ufZoS4g_QeVnRm6fNt64HW4e7_qzz3XrA3dX3lxd4NVZ2BS5g10dobkEUFm5YLhLOZxvGlVm8bPEib9H7Ou8cEOG0AqsBViXgIXU_NoDNH6KTow9fZsdkukWBBMHkmghjXGq1T6qOQbcAz5wwWnkdmyDLPTUyUdo6lbwPInAXhNBRMtbSVhgu2CN00C_79ATh2qvkWm50VDX3jfNcihgdxCBMuTaqCtXbSbZhKjGeb7qY2wI1tLQjXyzwxWa-2KZCr3ddVmN9jX8Rv8-c2xHm0tjlBUiMnTTNJkBoKphImYFegXkRJIDgEJUOSTShQodbvttJXwdLAQdzQHcS_vFy1wyaltMnrk_LTabJ8ZTUwlTo8Sgmu5Gw2kCcxWiF1J4A7Q11v6Xvzko175w5NQ18881W1H4N668z8fS_qJ-h2zSrQs0I1YfoYP19k55DLLX2L4oW_QSePRl7
  priority: 102
  providerName: Springer Nature
Title Interleukin-10 inhibits interleukin-1β production and inflammasome activation of microglia in epileptic seizures
URI https://link.springer.com/article/10.1186/s12974-019-1452-1
https://www.ncbi.nlm.nih.gov/pubmed/30922332
https://www.proquest.com/docview/2211408661
https://www.proquest.com/docview/2200786859
https://pubmed.ncbi.nlm.nih.gov/PMC6437919
https://doaj.org/article/e2607c9d239145c3b5c6549cd78ce51c
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLbGJiFeEHfKRmUknkCBJL4_INRVm6ZKTAio1LfIdpwtok26XqTBz-KH8Js4dtJAofDEUyr7OLHOxT6fj3sOQs-ploCOWRIRwuOIOhdHRiYusgZ-SkOY0SHb5zk_G9PRhE320Ka8VcvA5U5o5-tJjRfTV9dXX96Cwb8JBi_56yXsWcLfpVBRQlkaARg6COEif5OPdkEFArt72gY2dw7b2ppCBv9dbueftyd_C6GGnen0DrrdupR40OjAXbTnqnvo5rs2aH4fXYVTv6lbfy4rWA9xWV2Wplwtcflr-_dveN5kfwVJYV3l0F2Ausz0sp457P__0Jze4rrAM3-N72JaaiDCbg4rC6w8Fi9d-XUN-P0BGp-efBqeRW2lhcgywlcRU0q7Qhon4tzKAiCcZkoKI_PE8lDLhrs0LbRwxlhmqbaMyZwTUqQFU5SRh2i_qiv3GOHYCKcLqmQuYmoSbShnea7BTyFCF7nooXjD5My2ach9NYxpFuCI5Fkjlwzkknm5ZEkPveiGzJscHP8iPvaS6wh9-uzQUC8ustYaMwcoTliVp0TBKEsMsxyAss2FtI4ltoeONnLPNiqZpYCVKSBADt941nWDNfoQi65cvfY03ufikqkeetSoSTcTEivwxUjaQ2JLgbamut1TlZch47ePrqoE3vlyo2o_p_VXTjz5H5w4RLdSbyExiVJ5hPZXi7V7Cm7YyvTRDTERfXQwGIw-juB5fHL-_gO0DvmwH442-sH8fgDeWTbA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQw0KpaCbgg3g0UMBJcQFFjO3acQ4UotNrSdoVQK_UW_EobsZtsN7tC8Fl8AJ_ANzHOY8vy6K23yJ5Ejmc8b88g9DxWEqxjTkLGRBTGzkWhlsSFRsOj1Ixr1VT7HIrBcfz-hJ-soB_9XRifVtnzxIZR28p4H_kmBUslBv1bkNeT89B3jfLR1b6FhupaK9itpsRYd7Fj3339AiZcvbX3DvD9gtLdnaO3g7DrMhAazsQs5GmqXC61SyJrZA7mi-JgiGtpiRFNHxfhKM1V4rQ23MTKcC6tYCynOU9j3zUCRMBa7B0oq2hte2f44WMvCxgoFLSLpRIpNmuQronP-khDEnMakiVp2DQN-Jem-3fC5h9R20YY7t5CNzstFr9pye42WnHlHXTtsIvT30XnjaNx5OafixJYMC7Ks0IXsxoXv4___I4nbcFZIA6sSgvTOVDoWNXV2GF_5aJ1GOMqx2OfOXg6KhQAYTcBZgbMzuDaFd_mU1ffQ8dXsu330WpZlW4d4UgnTuVxKm0SxZooHQturQLViCUqt0mAon6TM9NVPvcNOEZZYwFJkbV4yQAvmcdLRgL0cvHKpC37cRnwtsfcAtBX7G4Gqulp1jGAzIHhmJjUUpbCW4ZpbgTY5sYm0jhOTIA2erxnHRupswuiD9CzxTQwAB_VUaWr5h7Gq3lC8jRAD1oyWayERSmof4wGKFkioKWlLs-UxVlTZNwHdFMC33zVk9rFsv67Ew8v_4mn6Prg6PAgO9gb7j9CN6g_BxELqdxAq7Pp3D0G_W6mn3SHCKNPV31ufwE6umTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQK1VcEG9CCxiJEyhqYsev4_JYlQUqJKjUm-VX2ojdZGl2L_1Z_BB-E-M8FhYKErcoHieWZ8Yzn2c8RuhZYSSgY5anlPIsLULIUivzkDoLj9JSZk1X7fOYH50Us1N2Otxz2o7Z7mNIsj_TEKs01avDpS97FZf8sAUrJWL2hErzgpEU4M-uZEoB-tqdTGafZuNiTMGikyGYeWXHLXPUVe2_ytX8M2Pyt7BpZ42mN9GNwY3Ek57vt9C1UN9Gex-GQPkd9LXb6ZuH9ZeqhjUQV_V5ZatVi6tf33__hpd9xVfgDja1h-YSRGRh2mYRcDzz0O_Y4qbEi5i6dzavDBDhsITVBFYbh9tQXa4Bs99FJ9M3n18dpcPtCqljlK9SmC4TSmmDyLyTJcA2w5QUVvrc8e7-Gh4IKY0I1jrmCuMYk55TWpKSqYLRe2inburwAOHMimDKQkkvssLmxhaceW_AN6HClF4kKBsnWbuh9Hi8AWOuOwgiue75ooEvOvJF5wl6vumy7Otu_Iv4ZeTchjCWzO5eNBdnetBAHQC5Cac8oQp6OWqZ4wCOnRfSBZa7BB2MfNeDHreaAD4uAPVx-MfTTTNoYAyrmDo060gT_SwO8peg-72YbEZCMwX-FyUJElsCtDXU7Za6Ou-qfMeIqsrhmy9GUfs5rL_OxMP_on6C9j6-nur3b4_f7aPrJGpFRlMiD9DO6mIdHoG7tbKPB5X6AQAcJig
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interleukin-10+inhibits+interleukin-1%CE%B2+production+and+inflammasome+activation+of+microglia+in+epileptic+seizures&rft.jtitle=Journal+of+neuroinflammation&rft.au=Yi+Sun&rft.au=Jiangjun+Ma&rft.au=Dongfang+Li&rft.au=Pinggan+Li&rft.date=2019-03-28&rft.pub=BMC&rft.eissn=1742-2094&rft.volume=16&rft.issue=1&rft.spage=1&rft.epage=13&rft_id=info:doi/10.1186%2Fs12974-019-1452-1&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e2607c9d239145c3b5c6549cd78ce51c
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-2094&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-2094&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-2094&client=summon